Real-time enrollment status for this braf v600e mutation clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:14 AM UTC
| NCT Number | NCT06610682 |
| Recruiting Status | Recruiting |
| Condition | BRAF V600E Mutation |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 19, 2026: Clinical trial NCT06610682 is currently recruiting participants. This early_phase1 study for braf v600e mutation is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06610682 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06610682 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.